Development of mammalian cell-enclosing subsieve-size agarose capsules (< 100 μm) for cell therapy

被引:76
作者
Sakai, S [1 ]
Kawabata, K [1 ]
Ono, T [1 ]
Ijima, H [1 ]
Kawakami, K [1 ]
机构
[1] Kyushu Univ, Fac Engn, Dept Chem Engn, Higashi Ku, Fukuoka 8128581, Japan
关键词
microcapsule; cell encapsulation; microencapsulation; transplantation; polysaccharide; cell viability;
D O I
10.1016/j.biomaterials.2004.11.043
中图分类号
R318 [生物医学工程];
学科分类号
0831 [生物医学工程];
摘要
Agarose capsules were prepared using a droplet breakup method in a coflowing stream. Subsieve-size capsules 76 +/- 9 mu m in diameter were obtained by extruding 4 wt% agarose solution from a needle (300 mu m inner diameter) at a velocity of 1.2 cm/s into an ambient liquid paraffin flow of 20.8 cm/s. Increasing the flow rate of the liquid paraffin and decreasing that of the agarose solution resulted in a decreased resultant capsule diameter. Reduction in diameter from several hundred micrometers to subsieve-size (< 100 mu m) enhanced molecular exchange and mechanical stability. Measurements based on the percentage of intact mitochondria in the cells demonstrated that the viability of the enclosed cells was independent of capsule diameter. No significant difference was observed between the viabilities of cells enclosed in capsules with diameters of 79 +/- 8 and 351 +/- 41 mu m (p = 0.43). Compared with cells seeded in a tissue culture dish, the cells enclosed in the subsieve-size capsules showed 89.2% viability. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4786 / 4792
页数:7
相关论文
共 19 条
[1]
The in vivo delivery of heterologous proteins by microencapsulated recombinant cells [J].
Chang, PL ;
Van Raamsdonk, JM ;
Hortelano, G ;
Barsoum, SC ;
MacDonald, NC ;
Stockley, TL .
TRENDS IN BIOTECHNOLOGY, 1999, 17 (02) :78-83
[2]
Therapeutic uses of microencapsulated genetically engineered cells [J].
Chang, TMS ;
Prakash, S .
MOLECULAR MEDICINE TODAY, 1998, 4 (05) :221-227
[3]
SEMIPERMEABLE MICROCAPSULES [J].
CHANG, TMS .
SCIENCE, 1964, 146 (364) :524-&
[4]
CRANK J, 1975, MATH DIFFUSION, P92
[5]
Effect of neovascularization-inducing bioartificial pancreas on survival of syngeneic islet grafts [J].
Gu, YJ ;
Miyamoto, M ;
Cui, WX ;
Xu, BY ;
Kawakami, Y ;
Yamasaki, T ;
Setoyama, H ;
Kinosita, N ;
Iwata, H ;
Ikada, Y ;
Imamura, M ;
Inoue, K .
TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) :2494-2495
[6]
Control of complement activities for immunoisolation [J].
Iwata, H ;
Murakami, Y ;
Ikada, Y .
BIOARTIFICIAL ORGANS II: TECHNOLOGY, MEDICINE, AND MATERIALS, 1999, 875 :7-23
[7]
IWATA H, 1986, JPN J ARTIF ORGANS, V15, P1493
[8]
MICROENCAPSULATED ISLETS AS BIOARTIFICIAL ENDOCRINE PANCREAS [J].
LIM, F ;
SUN, AM .
SCIENCE, 1980, 210 (4472) :908-910
[9]
Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan [J].
Lim, ST ;
Martin, GP ;
Berry, DJ ;
Brown, MB .
JOURNAL OF CONTROLLED RELEASE, 2000, 66 (2-3) :281-292
[10]
LOWRY OH, 1951, J BIOL CHEM, V193, P265